CONTACT US   |  (864) 397-5101

Clemson, Nephron Highlighted as Pharma Robots Market on Track for Remarkable 13.8% Growth


The pharma robots market is poised for substantial growth, with a projected annual surge of 13.8%, catapulting its anticipated worth to an impressive US$ 683.4 million by the year 2032. This surge underscores the increasing integration of robotics in the pharmaceutical industry, where automation plays a pivotal role in enhancing efficiency, precision, and overall productivity. The escalating demand for advanced pharmaceutical manufacturing processes and the need for high-throughput solutions are key factors driving this robust growth.

As the industry continues to embrace technological advancements, the pharma robots market is positioned as a critical player in shaping the future of pharmaceutical production, promising innovative solutions and transformative outcomes for the global healthcare landscape.

Request a Sample Report for Comprehensive Insights

To avoid drug overfill and minimize adulteration, Clemson University and Nephron Pharmaceuticals Corporation, for instance, have developed a tabletop robot that can fill, cap, and seal sterile pre-filled syringes. Syringe filling is still a highly controlled operation that requires specialist workers to complete in ISO-certified clean rooms in the absence of robots. To help hospitals and other healthcare facilities deal with a shortage of pre-filled needles, a robot was created.

Key Takeaways from the Pharma Robots Market Report:

  • The global Pharma Robots Market is expected to reach a market size of US$ 188.6 Million by 2022.  
  • The Traditional Robots segment is expected to account for the highest CAGR of 14.5% during the forecast period. 
  • United States to remain the most dominant market with an absolute dollar growth opportunity of US$ 153.4 Million during 2022 – 2032. 
  • The market in Japan is set to experience the highest CAGR of 16.1% during the 2022-2032 forecast period.

Competitive Landscape:
The market is fiercely competitive, where key players are increasingly focused on obtaining a competitive advantage. The key companies in the Pharma Robots Market are focused on R&D to produce innovative technological solutions. 

  • In December 2021, the Marchesini Group-Neri Division’s BL-A309 was displayed at FCE Pharma, a flexible solution for Print&Check and serialization processes that allow users to swiftly install all of the major pharmaceutical traceability devices on the market, from laser printers to ink-jet technologies. 
  • In December 2021, Universal Robots launched a virtual pharma event, where managers, experts, and other professionals in the pharmaceutical and medical technology industries learned about the various possibilities that robots provide. Universal Robots can be promising in the pharmaceutical industry and are already generating a significant buzz in the market. 
  • In May 2021, Fanuc augmented its SCARA robot line to provide more reach and payload alternatives to companies that are looking to automate assembly, packaging, pick-and-place, and inspection processes. New models with payload capacities of 3, 6, and 20 kg are SR-3iA, SR-6iA, SR-12iA, and SR-20iA. The reach of the models ranges from 400 to 1,000 mm.

Leading Key Players:

  • ABB Ltd.
  • Universal Robots
  • Kawasaki Heavy Industries Ltd.
  • Yaskawa Electric Corporation
  • FANUC America Corporation
  • Marchesini Group S.P.A
  • Seiko Epson Corporation
  • Denso Wave Incorporation
  • Jianjia Robots

Pharma Robots Market Segmentation:

By Product Type:

  • Traditional Robots
  • Articulated Pharmaceutical Robots
  • SCARA Pharmaceutical Robots
  • Delta Pharmaceutical Robots
  • Cartesian Pharmaceutical Robots
  • Dual-arm Pharmaceutical Robots
  • Collaborative Pharmaceutical Robots

By Application:

  • Robots for Pricking and Packaging
  • Robots for Inspection of Pharmaceutical Drugs
  • Robots for Laboratory Applications

By End-Use:

  • Robots for Pharmaceutical Companies
  • Robots for Laboratories Applications

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.